Health Professional Radio - Podcast
Phase 1 Clinical Trial of COVID-19 Vaccine UB-612
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:09:15
- Mas informaciones
Informações:
Sinopsis
Mei Mei Hu, JD, co-founder and co-CEO and Peter Diamandis, MD, co-founder and vice chairman at COVAXX, a division of United Biomedical, discuss UB-612, which could be the first multitope peptide-based vaccine for COVID-19 based on a commercially proven platform that has shown promising efficacy in animals and is safe and scalable. In September 2020 the first healthy adult volunteers were dosed with UB-612 in the company's Phase 1 trial in Taiwan.